Artemisitene Ameliorates Diabetic Wounds by Inhibiting Ferroptosis Through Activation of the Nrf2/GPX4 Pathway
Food Science & Nutrition · 2025-09 · 13 (9)
DOI: 10.1002/fsn3.70952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Science & Nutrition, online erschienen am 17.09.2025. Verfasst von Xu Honghao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic wounds are hard to heal due to ferroptosis, a specific type of cell death triggered by high blood sugar in human umbilical vein endothelial cells (HUVECs) in the lining of blood vessels. Ferroptosis occurs as a result of excessive iron accumulation and lipid peroxidation. The resulting impairment in endothelial function and tissue scaffolding creates a persistent barrier against effective wound healing. Our study found that artemisitene (ATT), a bioactive compound derived from the herb Artemisia annua , speeded up diabetic wound healing by blocking ferroptosis through the Nrf2 (NFE2 like bZIP transcription factor 2, also known as NRF2: Nuclear factor erythroid 2‐related factor 2)/GPX4 (Glutathione peroxidase 4) pathway. In studies with HG (high glucose)‐damaged HUVECs, treatment with ATT (20 μM) effectively counteracted harmful iron buildup and lipid peroxidation, while also restoring mitochondrial health and reducing the levels of damaging reactive oxygen species (ROS). Computational modeling confirmed that ATT binds tightly to both Nrf2 and GPX4 molecules. Notably, when Nrf2 was blocked, ATT completely lost its protective effect, indicating that Nrf2 is essential for its action. In diabetic rats, applying ATT directly to wounds (20 mg/kg/day) significantly accelerated the rate of wound closure. This treatment worked by triggering two key regenerative processes: stronger new blood vessel growth and better‐organized collagen structure. In practical terms, ATT prevents diabetic wound complications through three connected mechanisms: it uses GPX4 to counteract lipid peroxides, leverages Nrf2 to restore healthy antioxidant balance, and regenerates endothelial cells to drive new blood vessel formation. As the first drug of its kind to target ferroptosis this way, ATT offers a promising multitarget approach for diabetic wounds, tackling the combined problems of oxidative damage, mitochondrial failure, and poor tissue regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China.
- Key Laboratory of Orthopaedics of Zhejiang Province Wenzhou China.
- Department of Ultrasonic Diagnosis The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China.
- Wenzhou Medical University Wenzhou China.
ORCID-Profile: Wu Hongqiang
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Honghao, X., Yitian, B., Yuan, Z., Zhengyang, L., Feiya, Z., Leyi, C., Weiyang, G., Anyuan, W., & Hongqiang, W. (2025). Artemisitene Ameliorates Diabetic Wounds by Inhibiting Ferroptosis Through Activation of the Nrf2/GPX4 Pathway. Food Science & Nutrition, 13(9). https://doi.org/10.1002/fsn3.70952
Vancouver
Honghao X, Yitian B, Yuan Z, Zhengyang L, Feiya Z, Leyi C, et al. Artemisitene Ameliorates Diabetic Wounds by Inhibiting Ferroptosis Through Activation of the Nrf2/GPX4 Pathway. Food Science & Nutrition. 2025;13(9). doi:10.1002/fsn3.70952
BibTeX
@article{Honghao2025,
author = {Honghao, Xu and Yitian, Bu and Yuan, Zhao and Zhengyang, Long and Feiya, Zhou and Leyi, Cai and Weiyang, Gao and Anyuan, Wang and Hongqiang, Wu},
title = {Artemisitene Ameliorates Diabetic Wounds by Inhibiting Ferroptosis Through Activation of the Nrf2/GPX4 Pathway},
journal = {Food Science & Nutrition},
year = {2025},
volume = {13},
number = {9},
doi = {10.1002/fsn3.70952}
}
EUVIMED